Patents by Inventor Robert J. Behme

Robert J. Behme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Useful hemi-hydrate form of a cerebral function enhancing agent
    Patent number: 5401744
    Abstract: The hemi-hydrate form of the cerebral function enhancing agent 1-[[1-[2-(trifluoromethyl)-4-pyrimidinyl]-4-piperidinyl]-methyl-2-pyrrolid inone, or BMY-21502 as it is more commonly designated, is an improved form of drug substance having equivalent biopharmaceutical properties compared to the known anhydrous form but providing cost, safety and ecological advantages in manufacture over the known anhydrous form.
    Type: Grant
    Filed: October 4, 1993
    Date of Patent: March 28, 1995
    Assignee: Bristol-Myers Squibb Company
    Inventor: Robert J. Behme
  • Lyophilized ifosfamide compositions
    Patent number: 5227373
    Abstract: Improved lyophilizate compositions of ifosfamide comprising urea as the primary excipient and, optionally, mesna, are produced in a modified freeze-drying process to give products with increased heat stability and extended shelf storage life.
    Type: Grant
    Filed: October 23, 1991
    Date of Patent: July 13, 1993
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Robert L. Alexander, Robert J. Behme, Joseph A. Scott, Dana Brooke
  • Process for buspirone hydrochloride polymorphic crystalline form conversion
    Patent number: 4810789
    Abstract: A process for conversion of one polymorphic crystalline form of buspirone into its other polymorphic crystalline form.
    Type: Grant
    Filed: August 28, 1987
    Date of Patent: March 7, 1989
    Assignee: Bristol-Myers Company
    Inventors: Robert J. Behme, Terry T. Kensler, Douglas G. Mikolasek